Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited will convene its first extraordinary general meeting of 2026 on 28 August 2026 at 10:00 a.m. in the company’s conference room at No. 45 Sha Mian North Street, Liwan District, Guangzhou.

Key agenda items: 1. Adoption of the “Remuneration Management Measures for Directors and Senior Management,” a comprehensive policy that will formalise compensation standards for the company’s board and senior executives. 2. Approval of the specific remuneration package for employee-representative director Mr. Liu Hong for the 2026 financial year.

Shareholder logistics: • Book closure for H-shareholders runs from 25 to 28 August 2026 (both days inclusive). • Only shareholders on record at the close of business on 24 August 2026 will be eligible to attend and vote. • Valid proxy forms must reach Computershare Hong Kong Investor Services Limited no later than 24 hours before the meeting.

The meeting was authorised at the third meeting of the tenth Board session, which will also act as the convenor. Attendance is expected from company directors, senior management and legal advisers. The event is scheduled for half a day, and shareholders will bear their own travel and accommodation costs.